New technology enables companies to build an auditing system for healthcare data – specifically using blockchain. As more and more medical data goes digital, the system will ensure that as a hospital shares patient records, they stay private, accurate and tamper-free. We speak to Mustafa Suleyman, co-founder and head of applied AI at DeepMind, a company that has joined with Britain's NHS to create machine learning services that can identify diseases and illness in medial scans and other health records.
Hospital design and construction Top
Centralised monitoring of hospital patients could improve hospital budgets and patient care. Nearly 44% of in-patient cardiac arrest cases are not attended to appropriately and 90% of all alarms in hospitals aren’t actionable. Centralised monitoring provides an off-site monitoring of patients by technicians to give patients and clinicians a second set of eyes while providing better care from a distance using sensors and high def cameras according to Dr Daniel Cantillon, chief wellness officer at the Cleveland Clinic.
A report by Australian medical researchers on cardiovascular disease has recommended an urgent update of clinical guidelines to include special consideration for the treatment of women. Cardiovascular disease is represented vastly differently between genders and many do not know the different signs. Chief researcher Maja-Lisa Lochen explains why women have been under diagnosed with the disease for so long and why new diagnostics research patterns should be set worldwide to help patient care.
Two leading names in pharma have signed a R&D collaboration agreement in the field of septic shock to develop a companion diagnostic test. This collaboration proposes to develop a test to allow a certain stratification of sepsis patients to ideally identify patients who are more likely to respond to treatment. We speak to Jean-Jacques Garaud, CEO of Inotrem, about septic shock and the issues facing the healthcare sector in beating it.
Diagnostics 3 Top
A push by regulatory bodies to curb the prevalence of influenza by the mid 2020s with an emphasis on better diagnostics means that new commercial opportunities and are opening up in the R&D sphere. The growing amount of R&D, technological advancements in diagnostic tests, and rising demand for influenza diagnosis are likely to propel this mark – and healthcare researchers are excited by what it could lead to. We speak to Dr Sarah Gilbert, professor of Vaccinology at the University of Oxford, and one of the UK’s leading experts on flu diagnostics, about the changes to the way the virus is being identified and what this will mean for future diagnostics availability.
Experts in infectious diseases, infection control and clinical microbiology from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), speak to Practical Patient Care. They discuss better diagnostics, managing infections and promoting science.
Wound care 1Top
Improving the provision of foot care services available to diabetes patients is “key” to cutting amputations, and potentially ulcers as well, according to UK researchers. The team who conducted the research stated that introduction of the ten key services was “accompanied by a sustained reduction in major diabetes-related amputation incidence”. We speak to Dr Richard Paisey, who led the study, about what this means health systems should do to better provide wound care for diabetic patients.
Wound care 2Top
The National Institute for Health and Care Excellence (NICE) issued the first briefing on innovative pressure ulcer prevention dressings. These new types of dressings help reduce friction and protect vulnerable areas of skin, and could be used to prevent pressure ulcers among hospital patients, according to studies already done. We speak to Elaine Thorpe, from University College London Hospitals, who worked on NICE’s study, about what this will lead to in wound care.
Wound care 3Top
Experts from the European Wound Management Association (EWMA) write for Practical Patient Care about the latest trends and developments in patient care ahead of their 2018 forum. They discuss how new advances emphasise the importance of improved and continued education of physicians, nurses, physical therapists and other healthcare professionals engaged in wound management.
Infection Control 1Top
Nearly 2,000 cases of needlestick injuries have been reported to the NHS in the past five years, but new technology and developments in needle technology are helping to prevent this and can reduce risk of infection – and help save money (in several ways). We speak to Rose Gallagher MBE, head of infection prevention and control at the Royal College of Nursing, about what these new inventions mean and what staff need to focus on to keep themselves safe.
Infection control 2Top
As experts around the world warn of a ‘post-antibiotic apocalypse’ and ‘the end of modern medicine’, Public Health England launches a major new campaign to help ‘Keep Antibiotics Working’. The campaign warns people that taking antibiotics when they are not needed puts them at risk of a more severe or longer infection, and urges people to take their doctor’s advice on antibiotics. The campaign is especially targeted at nurses – we speak to Professor Paul Cosford, medical director at Public Health England, about what this will mean for patient care.
Operating room technologyTop
What is the ultimate set up for an operating room? We speak to Sarah Cohen, MD, from Brigham and Women’s Hospital, a surgeon who has specialised in the study of the perfect way to work your operating theatre. Cohen explains to Practical patient Care about the best technology on offer from ergonomics, to lasers and operating tables. We give you the ultimate rundown of the do’s and don’ts of how to employ the best facilities in your theatre.
A new project between Novartis and London’s Royal Marsden Hospitals’ Partners Cancer Vanguard aims to improve quality of care for cancer patients, by expanding the role of oncology pharmacists. The two-year pilot is designed to help address increasing demand on oncology service by ensuring quick access to treatments, drug prescription verification, and address issues with the delivery of treatments, i.e. using a mobile chemotherapy bus service to increase convenience to patients. We speak to Barak Palatchi, oncology general manager, Novartis UK, and Jatinder Harchowal, clinical director, Royal Marsden NHS Foundation Trust, about how collaboration is key to success, and what it could mean if the trial is successful and gets rolled out to more areas.